Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome
- PMID: 9050876
- PMCID: PMC20014
- DOI: 10.1073/pnas.94.5.1896
Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome
Abstract
N-acetyl-L-leucyl-L-leucyl-L-norleucinal (LLnL), which reversibly inhibits the proteasome in addition to other proteases, and a more specific irreversible inhibitor of the proteasome, lactacystin, were found to cause the accumulation of major histocompatibility complex (MHC) class I heavy chains in the cytosol of the beta2-microglobulin-deficient cell line Daudi and the TAP-deficient cell line .174. These cell lines, which are severely impaired in their ability to fold MHC class I heavy chain, showed an accumulation of soluble class I heavy chains at different rates over a period of hours in the presence of LLnL. The accumulation of soluble class I heavy chains in the presence of either LLnL or lactacystin was easily revealed in Daudi and .174 but almost undetectable in a Daudi transfectant expressing beta2-microglobulin and in 45.1, the wild-type parent of .174. The soluble class I heavy chain was also found to be devoid of its N-linked glycan and to be located in the cytosol. When the gene for ICP47, a herpes simplex virus protein that blocks the translocation of peptides into the endoplasmic reticulum, was transfected into 45.1, a similar accumulation of soluble MHC class I heavy chain was detectable. These data suggest that in cells where the MHC class I molecule is unable to assemble properly, the misfolded heavy chain is removed from the endoplasmic reticulum to the cytosol, deglycosylated, and degraded by the proteasome.
Figures





References
-
- Williams D B, Watts T H. Curr Opin Immunol. 1995;7:77–84. - PubMed
-
- Tector M, Salter R D. J Biol Chem. 1995;270:19638–19642. - PubMed
-
- Sadasivan B, Lehner P J, Ortmann B, Spies T, Cresswell P. Immunity. 1996;5:103–114. - PubMed
-
- Coux O, Tanaka K, Goldberg A L. Annu Rev Biochem. 1996;65:801–847. - PubMed
-
- Howard J C. Curr Opin Immunol. 1995;7:69–76. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources